Elevated Cellular PD1/PD-L1 Expression Confers Acquired Resistance to Cisplatin in Small Cell Lung Cancer Cells

Although small cell lung cancer (SCLC) is highly responsive to chemotherapies (e.g., cisplatin-etoposide doublet), virtually almost all responsive SCLC patients experience disease recurrence characterized by drug resistance. The mechanisms underlying cisplatin resistance remain elusive. Here we repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Fei, Pang, Jiuxia, Peng, Yong, Molina, Julian R., Yang, Ping, Liu, Shujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017656/
https://www.ncbi.nlm.nih.gov/pubmed/27610620
http://dx.doi.org/10.1371/journal.pone.0162925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017656/
https://www.ncbi.nlm.nih.gov/pubmed/27610620
http://dx.doi.org/10.1371/journal.pone.0162925

Ejemplares similares